The biology and role of CD44 in cancer progression: therapeutic implications

C Chen, S Zhao, A Karnad, JW Freeman - Journal of hematology & …, 2018 - Springer
CD44, a non-kinase transmembrane glycoprotein, is overexpressed in several cell types
including cancer stem cells and frequently shows alternative spliced variants that are …

DNA hypermethylation in disease: mechanisms and clinical relevance

M Ehrlich - Epigenetics, 2019 - Taylor & Francis
Increasing numbers of studies implicate abnormal DNA methylation in cancer and many non-
malignant diseases. This is consistent with numerous findings about differentiation …

Epigenetics in cancer: fundamentals and beyond

S Biswas, CM Rao - Pharmacology & Therapeutics, 2017 - Elsevier
Activation of oncogenes or the deactivation of tumor suppressor genes has long been
established as the fundamental mechanism leading towards carcinogenesis. Although this …

EYA4 promotes breast cancer progression and metastasis through its role in replication stress avoidance

B de la Peña Avalos, R Tropée, PHG Duijf, E Dray - Molecular Cancer, 2023 - Springer
Abstract The Eyes Absent (EYA) family of proteins is an atypical group of four dual-
functioning protein phosphatases (PP), which have been linked to many vital cellular …

Systematic evaluation of library preparation methods and sequencing platforms for high-throughput whole genome bisulfite sequencing

L Zhou, HK Ng, DI Drautz-Moses, SC Schuster… - Scientific reports, 2019 - nature.com
Whole genome bisulfite sequencing (WGBS), with its ability to interrogate methylation status
at single CpG site resolution epigenome-wide, is a powerful technique for use in molecular …

Methylation Dynamics of RASSF1A and Its Impact on Cancer

G Malpeli, G Innamorati, I Decimo, M Bencivenga… - Cancers, 2019 - mdpi.com
5-methyl cytosine (5mC) is a key epigenetic mark entwined with gene expression and the
specification of cellular phenotypes. Its distribution around gene promoters sets a barrier for …

A DNA methylation signature to improve survival prediction of gastric cancer

Y Peng, Q Wu, L Wang, H Wang, F Yin - Clinical epigenetics, 2020 - Springer
Abstract Background The current Union International Committee on Cancer or the American
Joint Committee on Cancer TNM stage system has shown valuable but insufficient …

SOX9: The master regulator of cell fate in breast cancer

S Jana, BM Krishna, J Singhal, D Horne… - Biochemical …, 2020 - Elsevier
SRY-related high-mobility group box 9 (SOX9) is an indispensable transcription factor that
regulates multiple developmental pathways related to stemness, differentiation, and …

Epigenetics of breast cancer: clinical status of epi-drugs and phytochemicals

S Shukla, D Penta, P Mondal, SM Meeran - Breast cancer metastasis and …, 2019 - Springer
Epigenetics refers to alterations in gene expression due to differential histone modifications
and DNA methylation at promoter sites of genes. Epigenetic alterations are reversible and …

[HTML][HTML] ROS promote hyper-methylation of NDRG2 promoters in a DNMTS-dependent manner: Contributes to the progression of renal fibrosis

Y Zhao, X Fan, Q Wang, J Zhen, X Li, P Zhou, Y Lang… - Redox Biology, 2023 - Elsevier
Renal fibrosis is the common histopathological feature of chronic kidney diseases (CKD),
and there is increasing evidence that epigenetic regulation is involved in the occurrence and …